Cart
sales@molnova.com
CEP-40125
CAS No. 1456608-94-8
CEP-40125( —— )
Catalog No. M34201 CAS No. 1456608-94-8
CEP-40125 (RXDX-107) is a DNA alkylating agent used for researching advanced solid tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCEP-40125
-
NoteResearch use only, not for human use.
-
Brief DescriptionCEP-40125 (RXDX-107) is a DNA alkylating agent used for researching advanced solid tumors.
-
DescriptionCEP-40125 (RXDX-107) is a DNA alkylating agent used for researching advanced solid tumors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDNA Alkylation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1456608-94-8
-
Formula Weight526.58
-
Molecular FormulaC28H45Cl2N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCCCCCCCCCCC)CCCC1=NC=2C=C(C=CC2N1C)N(CCCl)CCCl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Picroside IV
Kutkoside is a mixture of iridoid glycosides namely, picroside II, Picroside IV and 6-ferulloylcatalpol, it may have antinociceptive and anti-inflammatory effects.
-
5-O-Coumaroylquinic ...
5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.
-
Ipamorelin 2acetate(...
Ipamorelin 2acetate is a growth-hormone-releasing peptide, induces longitudinal bone growth in rats.In vitro, ipamorelin released GH from primary rat pituitary cells with a potency and efficacy similar to GHRP-6 (ECs) = 1.3+/-0.4nmol/l and Emax = 85+/-5% vs 2.2+/-0.3nmol/l and 100%).?
